REGN   $737.45  -0.90% Market Closed After Close 737.45 0.0

Regeneron Pharmaceuticals, Inc.

EMA (20): 2026-03-10 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (50): 2026-03-12 the price crossed down the moving average line and formed a short-term downside trend.

EMA (100): 2025-10-17 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: entrance to the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: signal line crossed the middle level.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: main and signal line crossing.

Trend Type flat and up
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -4.29%
EMA (20) date of signal March 10, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -1.03%
EMA (50) date of signal March 12, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 27.83%
EMA (100) date of signal Oct. 17, 2025, 3 a.m.
RSI Signals bearish recovery
RSI (14) Yield -0.70%
RSI (14) date of signal March 18, 2026, 3 a.m.
MACD Signals bearish
MACD Yield -2.65%
MACD date of signal March 17, 2026, 3 a.m.
Stochastic Signals bearish recovery
Stochastic Yield 0.0
Stochastic date of signal March 19, 2026, 3 a.m.
Updated March 19, 2026, 11:01 p.m.